Notification. Changes in Gammalon package
27/04/2019
Why does the packaging change?
Daiichi Sankyo, the manufacturer of Gammalon, starting from March 1, 2019 transferred all rights to the production and distribution of Gammalon in Japan, as well as a number of other medicines, to Alfresa Pharma (press release in Japanese is available by the following link: https://www.medicallibrary-dsc.info/announce/other/pdf-data/2018/1811stop_act_ect60.pdf). In this regard, there are minor changes regarding the packaging of Gammalon.
What will change in the packaging of Gammalon?
Specific changes affect the packaging of the goods. Below is a comparison of two packages of a series released before March 1 and after March 1, 2019. Top photo of new packaging, bottom photo of the old packaging. Please pay attention!